|Bid||5.33 x 1200|
|Ask||5.84 x 1000|
|Day's Range||5.27 - 5.59|
|52 Week Range||5.15 - 17.38|
|Beta (5Y Monthly)||2.38|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 22, 2022 - Mar 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.14|
Stockholm, V7, based Investment company HealthInvest Partners AB (Current Portfolio) buys McKesson Corp, Cardinal Health Inc, AmerisourceBergen Corp, Bristol-Myers Squibb Co, AbbVie Inc, sells Supernus Pharmaceuticals Inc, Accuray Inc, Aldeyra Therapeutics Inc, Rigel Pharmaceuticals Inc, Evolus Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, HealthInvest Partners AB.
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q1 2022.
NEWPORT BEACH, Calif., January 05, 2022--Evolus announces that it has further strengthened and diversified its Board of Directors with the appointment of Brady Stewart.